Antibody data
- Antibody Data
- Antigen structure
- References [30]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66591-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- FASN antibody
- Antibody type
- Monoclonal
- Description
- FASN antibody (Cat. #66591-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: IF, IHC, WB, ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1B6E4
- Vial size
- 20ul, 150ul
Submitted references NUDT7 Modulates the UBA52-SREBF1 Signaling Axis to Promote PRRSV Replication via Lipid Synthesis.
ANXA1 overexpression promotes B cell acute lymphoblastic leukemia progression and resistance by regulating fatty acid metabolism through PI3K/Akt signaling.
Liver-Targeting Nanoparticles GA-MSe@AR Treat NAFLD Through Dual Lipid-Lowering and Antioxidant Efficacy.
The IGF2BP3-FASN axis drives lipid metabolic reprogramming to promote brain colonization in non-small cell lung cancer.
Role of a low-molecular-weight polysaccharide from Boletus edulis Bull: Fr. in modulating gut microbiota and metabolic disorders.
Multi-omics joint analysis: Pachymic acid ameliorated non-alcoholic fatty liver disease by regulating gut microbiota.
Radiation Promotes Acute and Chronic Damage to Adipose Tissue.
Integrated proteogenomic characterization of ampullary adenocarcinoma.
Hericium erinaceus Protein Alleviates High-Fat Diet-Induced Hepatic Lipid Accumulation and Oxidative Stress In Vivo.
Hepatoblastoma-Derived Exosomal FASN Affected the Differentiation of Hepatic Stellate Cells Into Cancer-Associated Fibroblasts by Regulating the Stability of HK2 and Mediating Histone Lactylation.
Riboflavin-PLGA nanoparticles enhance the effectiveness of the pyruvate carboxylase inhibitor ZY-444 in targeting lipogenesis in colon and breast cancer.
FGF21-MAPK1 Imbalance Disrupts Hepatic Lipid Metabolism in Dairy Cow Ketosis.
SESN2 maintains cartilage homeostasis by SREBP1-mediated lipid metabolism during osteoarthritis progression.
Jatrorrhizine retard obesity by modulating transcription factor c-Jun/c-Fos to downregulate Mmp12-mediated inflammation.
siRNA nanoparticle targeting Usp20 lowers lipid levels and ameliorates metabolic syndrome in mice.
USP14 increases the sensitivity of retinoblastoma to cisplatin by mediating the ferroptosis.
Defects in CYB5A and CYB5B impact sterol-C4 oxidation in cholesterol biosynthesis and demonstrate regulatory roles of dimethyl sterols.
Let-7a-5p abrogates progression of papillary thyroid carcinoma cells by decreasing nuclear receptor subfamily 6 group a member 1-mediated lipogenesis.
TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis.
Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer.
PEDV inhibits HNRNPA3 expression by miR-218-5p to enhance cellular lipid accumulation and promote viral replication.
ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis.
Role of Gltp in Maturation of Oligodendrocytes Under the Regulation of Nkx2.2.
Ubiquitin specific peptidase 38 promotes the progression of gastric cancer through upregulation of fatty acid synthase.
CRISPR Cas9-mediated ablation of pyruvate carboxylase gene in colon cancer cell line HT-29 inhibits growth and migration, induces apoptosis and increases sensitivity to 5-fluorouracil and glutaminase inhibitor.
Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis.
SIRT1/mTOR pathway-mediated autophagy dysregulation promotes Pb-induced hepatic lipid accumulation in HepG2 cells.
Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.
OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis.
Yan Y, Li C, Zhang J, Li R, Yin B, Zhang S, Zhang Y, Zhang X, Han J, Huang J
International journal of biological sciences 2026;22(3):1590-1610
International journal of biological sciences 2026;22(3):1590-1610
ANXA1 overexpression promotes B cell acute lymphoblastic leukemia progression and resistance by regulating fatty acid metabolism through PI3K/Akt signaling.
Liu P, Ma D, Pan C, Kang Q, Wang Y, Zhang M, Wang J
Molecular and cellular biochemistry 2026 Mar;481(3):1401-1414
Molecular and cellular biochemistry 2026 Mar;481(3):1401-1414
Liver-Targeting Nanoparticles GA-MSe@AR Treat NAFLD Through Dual Lipid-Lowering and Antioxidant Efficacy.
Lei S, Wu Q, Zhang B, Lu M, Xia Y, Li N
International journal of nanomedicine 2025;20:5017-5037
International journal of nanomedicine 2025;20:5017-5037
The IGF2BP3-FASN axis drives lipid metabolic reprogramming to promote brain colonization in non-small cell lung cancer.
Li J, Ouyang S, Lin Z, Peng K, Yan J, Lu M, Ding W, Mo J, Su Y, Wang L, Yue P, Lu JJ, Yao X, Wang Y, Zhang X
Cell death & disease 2025 Oct 6;16(1):684
Cell death & disease 2025 Oct 6;16(1):684
Role of a low-molecular-weight polysaccharide from Boletus edulis Bull: Fr. in modulating gut microbiota and metabolic disorders.
Zhao M, Liu Z, Geng Y, Lv X, Xu J, Zhao X, Yu Z, Zhu R, Li M, Han F, Ma X, Gu N
International journal of biological macromolecules 2025 May;309(Pt 3):142789
International journal of biological macromolecules 2025 May;309(Pt 3):142789
Multi-omics joint analysis: Pachymic acid ameliorated non-alcoholic fatty liver disease by regulating gut microbiota.
Ren G, Lin Y, Fu Y, Liu F, Wang R, Zhang C, Qiu J, Chen L, Dou X
Food research international (Ottawa, Ont.) 2025 May;209:116178
Food research international (Ottawa, Ont.) 2025 May;209:116178
Radiation Promotes Acute and Chronic Damage to Adipose Tissue.
Liermann-Wooldrik KT, Kosmacek EA, McDowell JA, Takkar S, Murthy D, Singh PK, Schott MB, Ponnusamy MP, Oberley-Deegan RE
International journal of molecular sciences 2025 Jun 12;26(12)
International journal of molecular sciences 2025 Jun 12;26(12)
Integrated proteogenomic characterization of ampullary adenocarcinoma.
Zhang Q, Xu X, Jiang D, Wang Y, Wang H, Zhu J, Tang S, Wang R, Zhao S, Li K, Feng J, Xiang H, Yao Z, Xu N, Fang R, Guo W, Liu Y, Hou Y, Ding C
Cell discovery 2025 Jan 7;11(1):2
Cell discovery 2025 Jan 7;11(1):2
Hericium erinaceus Protein Alleviates High-Fat Diet-Induced Hepatic Lipid Accumulation and Oxidative Stress In Vivo.
Lu H, Yang S, Li W, Zheng B, Zeng S, Chen H
Foods (Basel, Switzerland) 2025 Jan 31;14(3)
Foods (Basel, Switzerland) 2025 Jan 31;14(3)
Hepatoblastoma-Derived Exosomal FASN Affected the Differentiation of Hepatic Stellate Cells Into Cancer-Associated Fibroblasts by Regulating the Stability of HK2 and Mediating Histone Lactylation.
Zhu Q, Zhou Y, Wang Y, Wu X, Hu Y, Zai H
Comprehensive Physiology 2025 Dec;15(6):e70080
Comprehensive Physiology 2025 Dec;15(6):e70080
Riboflavin-PLGA nanoparticles enhance the effectiveness of the pyruvate carboxylase inhibitor ZY-444 in targeting lipogenesis in colon and breast cancer.
Siritutsoontorn S, Manohong P, Sawektreeratana N, Kuhakarn C, Katewongsa KP, Jitrapakdee S
Scientific reports 2025 Dec 30;16(1):125
Scientific reports 2025 Dec 30;16(1):125
FGF21-MAPK1 Imbalance Disrupts Hepatic Lipid Metabolism in Dairy Cow Ketosis.
Xu JJ, Yang F, Chen ZX, Wang ZP, Wang ZX, Deng ZH, Xu CJ, Chen FH, Zhang W, Liu Y, Cai YF
Life (Basel, Switzerland) 2025 Aug 24;15(9)
Life (Basel, Switzerland) 2025 Aug 24;15(9)
SESN2 maintains cartilage homeostasis by SREBP1-mediated lipid metabolism during osteoarthritis progression.
Liu Z, Jiang H, Zhang Z, Jiang R, Wang R, Li J, Li W, Tan G, Fei Y, Lv Z, Guo H, Sun Z, Wu R, Shi H, Shi D
iScience 2025 Aug 15;28(8):113097
iScience 2025 Aug 15;28(8):113097
Jatrorrhizine retard obesity by modulating transcription factor c-Jun/c-Fos to downregulate Mmp12-mediated inflammation.
Ma Z, Li J, Zhu J, Yang Z, Li X, Wang H, Tang Q, Zhou Y, Manzoor R, Chen X, Ma H, Ye X
International immunopharmacology 2025 Apr 16;152:114405
International immunopharmacology 2025 Apr 16;152:114405
siRNA nanoparticle targeting Usp20 lowers lipid levels and ameliorates metabolic syndrome in mice.
Ding Y, Chen QB, Xu H, Adi D, Ding YW, Luo WJ, Zhu WZ, Xu JC, Zhao X, Shi XJ, Luo J, Yin H, Lu XY
Journal of lipid research 2024 Sep;65(9):100626
Journal of lipid research 2024 Sep;65(9):100626
USP14 increases the sensitivity of retinoblastoma to cisplatin by mediating the ferroptosis.
Liu H, Gan Q, Lai Y, Pan Z, Jin Q, Li J, Wang N, Jiao S, Chai Y
Naunyn-Schmiedeberg's archives of pharmacology 2024 Nov;397(11):8671-8680
Naunyn-Schmiedeberg's archives of pharmacology 2024 Nov;397(11):8671-8680
Defects in CYB5A and CYB5B impact sterol-C4 oxidation in cholesterol biosynthesis and demonstrate regulatory roles of dimethyl sterols.
Ma MY, Deng G, Zhu WZ, Sun M, Jiang LY, Li WH, Liu YB, Guo L, Song BL, Zhao X
Cell reports 2024 Nov 26;43(11):114912
Cell reports 2024 Nov 26;43(11):114912
Let-7a-5p abrogates progression of papillary thyroid carcinoma cells by decreasing nuclear receptor subfamily 6 group a member 1-mediated lipogenesis.
Zhao T, Sun J, Lu X, Liu L, Chen L, Zhao W, Zhou B
Journal of biochemical and molecular toxicology 2024 Jan;38(1):e23572
Journal of biochemical and molecular toxicology 2024 Jan;38(1):e23572
TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis.
Hao XL, Lv YF, Li DF, Bai FH, Gong J, Pan GQ, Su LX, Wang YL, Fu WL, Liu B, Huang L, Yan D, Tan QL, Liu JY, Guo QN
Journal of translational medicine 2024 Jan 2;22(1):6
Journal of translational medicine 2024 Jan 2;22(1):6
Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer.
Zhou L, Du K, Dai Y, Zeng Y, Luo Y, Ren M, Pan W, Liu Y, Zhang L, Zhu R, Feng D, Tian F, Gu C
Journal of translational medicine 2024 Jan 13;22(1):55
Journal of translational medicine 2024 Jan 13;22(1):55
PEDV inhibits HNRNPA3 expression by miR-218-5p to enhance cellular lipid accumulation and promote viral replication.
Shi X, Zhang Q, Yang N, Wang Q, Zhang Y, Xu X
mBio 2024 Feb 14;15(2):e0319723
mBio 2024 Feb 14;15(2):e0319723
ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis.
Mo Y, Han Y, Chen Y, Fu C, Li Q, Liu Z, Xiao M, Xu B
Molecular cancer 2024 Dec 19;23(1):274
Molecular cancer 2024 Dec 19;23(1):274
Role of Gltp in Maturation of Oligodendrocytes Under the Regulation of Nkx2.2.
Zhang C, Chen Z, Zhang D, Wang X, Qiu M, Tan Z
Molecular neurobiology 2023 Sep;60(9):4897-4908
Molecular neurobiology 2023 Sep;60(9):4897-4908
Ubiquitin specific peptidase 38 promotes the progression of gastric cancer through upregulation of fatty acid synthase.
Zheng Z, Shang Y, Xu R, Yan X, Wang X, Cai J, Bai Z, Liu X, Yin J, Zhang J, Zhang Z
American journal of cancer research 2022;12(6):2686-2696
American journal of cancer research 2022;12(6):2686-2696
CRISPR Cas9-mediated ablation of pyruvate carboxylase gene in colon cancer cell line HT-29 inhibits growth and migration, induces apoptosis and increases sensitivity to 5-fluorouracil and glutaminase inhibitor.
Ngamkham J, Siritutsoontorn S, Saisomboon S, Vaeteewoottacharn K, Jitrapakdee S
Frontiers in oncology 2022;12:966089
Frontiers in oncology 2022;12:966089
Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis.
Han Z, Liu M, Xie Y, Zeng K, Zhan Z, Chen Y, Wang L, Chen X, Luo Y, Zeng Y, Zhan H, Lin Y, Zhang K, Zhu X, Liu S, Luo X, Zhou A
Cell death discovery 2022 Nov 4;8(1):445
Cell death discovery 2022 Nov 4;8(1):445
SIRT1/mTOR pathway-mediated autophagy dysregulation promotes Pb-induced hepatic lipid accumulation in HepG2 cells.
Zhao Y, Mao A, Zhang R, Guan S, Lu J
Environmental toxicology 2022 Mar;37(3):549-563
Environmental toxicology 2022 Mar;37(3):549-563
Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.
Zou G, Zhang X, Wang L, Li X, Xie T, Zhao J, Yan J, Wang L, Ye H, Jiao S, Xiang R, Shi Y
Theranostics 2020;10(15):6839-6853
Theranostics 2020;10(15):6839-6853
OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W, Xu L, Yu X, Zhang G, Guo H, Liu H, Song G, Weng S, Dong L, Zhu J, Liu T, Guo C, Shen X
Journal of hepatology 2020 May;72(5):909-923
Journal of hepatology 2020 May;72(5):909-923
Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis.
Lu XY, Shi XJ, Hu A, Wang JQ, Ding Y, Jiang W, Sun M, Zhao X, Luo J, Qi W, Song BL
Nature 2020 Dec;588(7838):479-484
Nature 2020 Dec;588(7838):479-484
No comments: Submit comment
No validations: Submit validation data